Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
Status:
Recruiting
Trial end date:
2023-09-20
Target enrollment:
Participant gender:
Summary
Burning mouth syndrome (BMS) is a syndrome characterized by burning and persistent oral pain,
ranging from mild to intense, in the absence of organic disorders of the oral cavity and with
a major impact on the quality of life of the sufferer. Although several etiological theories
have been proposed to explain BMS, none has been universally accepted to date, and its origin
remains unclear. Currently, several scientific evidences would suggest that underlying BMS
would be alterations in certain neuropathic mechanisms.
The purpose of the study is to evaluate the efficacy of Diazepam 1% oral gel in the treatment
of burning mouth syndrome.